Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rudin

Showing results (51-60 of 576) with videos related to

Pageof 58
Sort By:
Magnetic Resonance Imaging|January 1, 1997
Analysis of tracer transit in rat brain after carotid artery and femoral vein administrations using linear system theoryM Rudin, N Beckmann, A Sauter
Cold Spring Harbor Perspectives in Medicine|June 10, 2020
Advances in Small-Cell Lung Cancer (SCLC) Translational ResearchBenjamin J Drapkin, Charles M Rudin
Annual Review of Medicine|January 1, 1997
Apoptosis and disease: regulation and clinical relevance of programmed cell deathC M Rudin, C B Thompson
Oncology (Williston Park, N.Y.)|March 2, 2010
Lung cancer in 'never-smokers': beyond EGFR mutations and EGFR-TK inhibitorsTimothy F Burns, Charles M Rudin
Molecular Cancer Research : MCR|December 1, 2005
Mammalian target of rapamycin promotes vincristine resistance through multiple mechanisms independent of maintained glycolytic rateDavid J Vanderweele, Charles M Rudin
Expert Opinion on Pharmacotherapy|May 19, 2012
Crizotinib in the treatment of non-small-cell lung cancerPatrick M Forde, Charles M Rudin
Expert Review of Clinical Pharmacology|July 18, 2017
Atezolizumab for the treatment of non-small cell lung cancerFernando C Santini, Charles M Rudin
Cancer|June 18, 2016
Missing the mark in FGFR1-amplified squamous cell cancer of the lungPaul K Paik, Charles M Rudin
Nature Reviews. Clinical Oncology|December 14, 2016
Small-cell lung cancer in 2016: Shining light on novel targets and therapiesCharles M Rudin, John T Poirier
Cancer Discovery|March 6, 2014
MYC, MAX, and small cell lung cancerCharles M Rudin, J T Poirier
Pageof 58

Showing results (51-60 of 576) with videos related to

Sort By:
Pageof 58
Magnetic Resonance Imaging|January 1, 1997
Analysis of tracer transit in rat brain after carotid artery and femoral vein administrations using linear system theoryM Rudin, N Beckmann, A Sauter
Cold Spring Harbor Perspectives in Medicine|June 10, 2020
Advances in Small-Cell Lung Cancer (SCLC) Translational ResearchBenjamin J Drapkin, Charles M Rudin
Annual Review of Medicine|January 1, 1997
Apoptosis and disease: regulation and clinical relevance of programmed cell deathC M Rudin, C B Thompson
Oncology (Williston Park, N.Y.)|March 2, 2010
Lung cancer in 'never-smokers': beyond EGFR mutations and EGFR-TK inhibitorsTimothy F Burns, Charles M Rudin
Molecular Cancer Research : MCR|December 1, 2005
Mammalian target of rapamycin promotes vincristine resistance through multiple mechanisms independent of maintained glycolytic rateDavid J Vanderweele, Charles M Rudin
Expert Opinion on Pharmacotherapy|May 19, 2012
Crizotinib in the treatment of non-small-cell lung cancerPatrick M Forde, Charles M Rudin
Expert Review of Clinical Pharmacology|July 18, 2017
Atezolizumab for the treatment of non-small cell lung cancerFernando C Santini, Charles M Rudin
Cancer|June 18, 2016
Missing the mark in FGFR1-amplified squamous cell cancer of the lungPaul K Paik, Charles M Rudin
Nature Reviews. Clinical Oncology|December 14, 2016
Small-cell lung cancer in 2016: Shining light on novel targets and therapiesCharles M Rudin, John T Poirier
Cancer Discovery|March 6, 2014
MYC, MAX, and small cell lung cancerCharles M Rudin, J T Poirier
Pageof 58